dashboard review first quarter of fy-2017€¦ · shah ss, srivastava r, keren r, wu s, et al....

17
Dashboard Review First Quarter of FY-2017 Joe Selby, MD, MPH Executive Director 1

Upload: others

Post on 11-Jul-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Dashboard Review First Quarter of FY-2017€¦ · Shah SS, Srivastava R, Keren R, Wu S, et al. Intravenous Versus Oral Antibiotics for Postdischarge Treatment of Complicated Pneumonia

Dashboard ReviewFirst Quarter of FY-2017

Joe Selby, MD, MPHExecutive Director

1

Page 2: Dashboard Review First Quarter of FY-2017€¦ · Shah SS, Srivastava R, Keren R, Wu S, et al. Intravenous Versus Oral Antibiotics for Postdischarge Treatment of Complicated Pneumonia

0

25

50

75

100

% Abstracts Posted toPCORI.org in <90 days

Perc

ent

0

25

50

75

100

% Peer Review processless than 5 Months

Perc

ent

1

2 2

0

10

20

30

Q2 Q3 Q4 Q1

Res

earc

h Pr

ojec

ts

Funds Committed to Research Project Performance

Draft Final Research Reports PCORI Peer Review

Research in PCORnet

Operating Budget

50

60

70

80

90

100

% of Projects On TrackPe

rcen

t

Board of Governors DashboardFirst Quarter FY-2017 (As of 12/31/2016)Our Goals: Increase Information, Speed Implementation, and Influence Research

Needs Board Attention

On TargetOff Target

Q1 2017Q4 2016Q3 2016Q2 2016

0 100 200 300 400 500$ Millions

Projected/Target

Inpu

tsPr

oces

sO

utpu

tsU

ptak

eU

se

Impact

3

4

16

0

10

20

30

40

Q2 Q3 Q4 Q1

Art

icle

s

Other Results

CERResults

Budgeted $428M for FY-2017

Public Reporting of Research Findings

Actual

Results Published in Literature Altmetrics

PCORI-funded

Externally Funded or Co-funded

Number of Publications with Altmetric Score >20

Target > 90%

Q2 Q3 Q4 Q1 0 20 40 60 80$ Millions

Budgeted $81M for FY-2017

Actual

1

1

2

0

5

10

15

Q2 Q3 Q4 Q1

Art

icle

s

Other Publications

Projects Underway in PCORnet (Cumulative)

Goal ThreeInfluencing Research

PCORI is credited as a model for Henry Ford Health System’s Patient Engagement Research Center (PERC), which brings together researchers and patient advisory groups to improve patient care

Goal TwoSpeeding Implementation

We awarded one of our first D&I projects to a PCORI-funded study on preventing non-administration of VTE prophylaxis to implement the intervention in two large hospital settings

Narrative Examples

Goal OneIncreasing Information

Use of a decision aid in patients with low risk chest pain increased understanding of risk and safely decreased the rate of admission to an observation unit for cardiac testing

Does not include Research Awards

Target > 90 %

0

25

50

75

100

% of DFRRs On Time

Perc

ent

Target > 90%

Q2 Q3 Q4 Q1NA Q1: NA

First data to be available in Q2-17

Target 100 %

Q1: NA

First data to be available in Q2/Q3-17

Too Early to Evaluate

Includes funds committed to PCORnet

8 14

2 3

19 23N=

CERResults

2

Page 3: Dashboard Review First Quarter of FY-2017€¦ · Shah SS, Srivastava R, Keren R, Wu S, et al. Intravenous Versus Oral Antibiotics for Postdischarge Treatment of Complicated Pneumonia

Chest pain is the second most common reason patients visit emergency departments across the United States. To avoid missing a heart attack diagnosis, doctors frequently admit patients to the hospital even when they are at very low risk. These low-risk admissions result in unnecessary testing, patient anxiety, and disruption in patients’ lives, as well as increased healthcare costs.

This study compared the effectiveness of shared decision making vs. usual care in choice of admission for observation and further cardiac testing or for referral for outpatient evaluation in patients with low risk chest pain. Use of the decision aid increased patient knowledge about their risk, increased engagement, and safely decreased the rate of admission to an observation unit for cardiac testing.

Results of PCORI Research: Shared Decision Making in ED for Evaluation of Low Risk Chest Pain Safely Decreases Hospital Admissions

”Patients can be effectively educated and engaged in the emergency care setting in decisions about testing and follow-up… it is feasible to do so in the flow of clinical care.

Hess EP, Hollander JE, Schaffer JT, et al. Shared Decision Making in Patients with Low Risk Chest Pain: Prospective Randomized Pragmatic Trial. BMJ. December 2016. 355:i6165

Results (Abstract): Compared with usual care, patients using the decision aid had greater knowledge of their risk for acute coronary syndrome and options for care (questions correct: decision aid, 4.2 v usual care, 3.6; mean difference 0.66, 95% CI 0.46 to 0.86), were more involved in the decision (observing patient involvement scores: decision aid, 18.3 v usual care, 7.9; 10.3, 9.1 to 11.5), and less frequently decided with their clinician to be admitted for cardiac testing (decision aid, 37% v usual care, 52%; absolute difference 15%; P<0.001). There were no major adverse cardiac events due to the intervention.

• Awarded 2012, Assessment of Prevention, Diagnosis, and Treatment Options project

• Principal Investigator: Erik Paul Hess, MD, MS, Mayo Clinic

3

Page 4: Dashboard Review First Quarter of FY-2017€¦ · Shah SS, Srivastava R, Keren R, Wu S, et al. Intravenous Versus Oral Antibiotics for Postdischarge Treatment of Complicated Pneumonia

Dissemination of Results:D&I Project for Preventing Venous Thromboembolism (VTE)

AHRQ has called VTE prevention in patients the number one strategy to improve patient safety in hospitals. A PCORI-funded study found that patients want to be educated on VTE, and that educating bedside nurses and implementing a patient-centered education intervention led to significant reduction in non-administration of VTE prophylaxis.

PCORI Dissemination Project:

This project aims to scale up the implementation of a patient-centered VTE prevention education intervention in 2 settings:

1. To all floors of the large, academic teaching hospital where the intervention was originally tested (Johns Hopkins)

2. To all floors of a medium-sized community, suburban, non-teaching hospital

The goal is to decrease refused doses of VTE prophylaxis among inpatients within these two hospitals. If successful, this D&I project will result in improved quality of patient-nurse communication and more informed patient decisions regarding the choice to take VTE pharmacologic prophylaxis.

Page 5: Dashboard Review First Quarter of FY-2017€¦ · Shah SS, Srivastava R, Keren R, Wu S, et al. Intravenous Versus Oral Antibiotics for Postdischarge Treatment of Complicated Pneumonia

19

6

14

19

6

12

6 57

2

100% 100%

86%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

0

10

20

30

40

Cycle 1 201612/13/2016

Cycle 2 2016(Not Yet Awarded)

Cycle 3 2016(Not Yet Awarded)

% o

f LO

Is A

ccep

ted

Num

ber

Letters of Intent SubmittedLetters of Intent AcceptedApplicationsAwardsLOI Acceptance Rate

Cycle dates = dates that awards were announcedSome LOIs not accepted due to administrative noncompliance

D&I PFA - Limited CompetitionLOIs, Applications, and Awards (All Cycles)

Competitive LOI beginning 2017

5

Page 6: Dashboard Review First Quarter of FY-2017€¦ · Shah SS, Srivastava R, Keren R, Wu S, et al. Intravenous Versus Oral Antibiotics for Postdischarge Treatment of Complicated Pneumonia

PCORI is credited with serving as a model for patient engagement at Henry Ford Health System Patient Engagement Research Center (PERC), which was created to develop the infrastructure for patient-centered outcomes research at Henry Ford Health System and improve the way Henry Ford delivers patient care and treatment of diseases. An AHRQ grant was awarded in 2013.

Goal: Henry Ford’s flexible engagement model facilitates meaningful dialog between patients, caregivers, physicians and researchers to address topics that matter to all.

Results of the PERC include:• Educating and engaging stakeholders through:

o Creation of a diverse Patient Advisor group (~300 currently enrolled)o Building Patient Advisors skills to collaborate as full members of research teams.o Implemented an education module to prepare researchers for effective engagement

• Expanding dedicated resources for 4 research function cores:o Patient Engagemento Study Design, Analysis and Measuremento Patient Data Networko Dissemination and Implementation

Influence Example:PCORI Credited with Serving as a Model for Patient Engagement in Research at Henry Ford Health System

PCORI’s support, resources and guidance have been key to PERC’s success, particularly PCORI website resources, and monthly guidance from the Pipeline to Proposal team– Karen Kippen

”6

Page 7: Dashboard Review First Quarter of FY-2017€¦ · Shah SS, Srivastava R, Keren R, Wu S, et al. Intravenous Versus Oral Antibiotics for Postdischarge Treatment of Complicated Pneumonia

676

555

257

374

0

100

200

300

400

500

600

700

800

900

1,000

Uni

que

Acce

sses

Unique AccessesBy Quarter (N=1862)

10

11

22

33

55

92

109

129

193

Health Educat. Specialist

Psychologist

Medical Assistant

Physician Assistant

Case Manager

Nurse Practitioner

Pharmacist

Physician

Nurse

Cumulative CME/CE Learners By Profession (N=707)

94

11598

147

0

25

50

75

100

125

150

175

200

225C

ertif

icat

es

CME/CE Certificates* By Quarter (N=454)

*Some learners earn multiple certificates, while many do not require certificates and access the course without seeking CME/CE

PCORI Engagement RubricCME/CE Activity released Jan 2016

53 Other or Unknown

Q2 Q3 Q4 Q1Q2 Q3 Q4 Q1

Influence on Research:Uptake of the PCORI Engagement Rubric

7

Page 8: Dashboard Review First Quarter of FY-2017€¦ · Shah SS, Srivastava R, Keren R, Wu S, et al. Intravenous Versus Oral Antibiotics for Postdischarge Treatment of Complicated Pneumonia

We actively monitor our projects, support them to be successful,and classify their progress as shown below

8

Page 9: Dashboard Review First Quarter of FY-2017€¦ · Shah SS, Srivastava R, Keren R, Wu S, et al. Intravenous Versus Oral Antibiotics for Postdischarge Treatment of Complicated Pneumonia

7067

72 73 7478 78

2125

22 20 2118 16

9 96 7 5 4 6

0

10

20

30

40

50

60

70

80

90

Q3-15 Q4-15 Q1-16 Q2-16 Q3-16 Q4-16 Q1-17

Perc

ent o

f Pro

ject

s (%

)

Green Zone

Yellow Zone

Off Track(Orange/Red)

AwardTerminated*

Project Status by Color ZonesQ3-15 to Q1-17

We are monitoring trends and shifts in project status

*Notice of Termination Issued, <1% in each quarter 9

Page 10: Dashboard Review First Quarter of FY-2017€¦ · Shah SS, Srivastava R, Keren R, Wu S, et al. Intravenous Versus Oral Antibiotics for Postdischarge Treatment of Complicated Pneumonia

Projects On TrackSubset of Projects in the Zone

0

10

20

30

40

% of Projects in theYellow Zone

% First Timein Yellow Zone

% Consecutively inYellow Zone(4+ quarters)

% in Yellow Zone thatimproved from Red or

Orange within past year

On Track, but Yellow Zone:Details

(Among All Projects Eligible for Color Evaluation) Q2-16 (N=326)Q3-16 (N=335)Q4-16 (N=367)Q1-17 (N=383)%

10

Page 11: Dashboard Review First Quarter of FY-2017€¦ · Shah SS, Srivastava R, Keren R, Wu S, et al. Intravenous Versus Oral Antibiotics for Postdischarge Treatment of Complicated Pneumonia

Projects Off TrackSubset of Projects in the or Zone

0

10

20

30

40

% Projects in theOrange or Red Zone

% First Time inOrange or Red

% Consecutively inOrange or Red Zone

(3+ quarters)

% Letter ofConcern Sent

% AwardTerminated

Percent of Projects Off Track:Details

(Among All Projects Eligible for Color Evaluation) Q2-16 (N=326)Q3-16 (N=335)Q4-16 (N=367)Q1-17 (N=383)%

11

Page 12: Dashboard Review First Quarter of FY-2017€¦ · Shah SS, Srivastava R, Keren R, Wu S, et al. Intravenous Versus Oral Antibiotics for Postdischarge Treatment of Complicated Pneumonia

DFRR SubmissionBased on DFRR Due Date in Contract

-5

-4

-3

-2

-1

0

1

2M

onth

s Ea

rly o

r Lat

e

Early, N=4

On Time, N=15 Late,N=2

Not Yet Turned In, N=2

Early, 4On Time,

15

Late, 2Not Yet

Turned In, 2

Timeliness of Q1-17 DFRR Submission

From Due Date to SubmissionN=23

How early or late were the Q1-17 DFRRs?

Target: 90% in on timeQ1-17: 82% in on time

Needs Board Attention

On TargetOff Target

Too Early to Evaluate

12

Page 13: Dashboard Review First Quarter of FY-2017€¦ · Shah SS, Srivastava R, Keren R, Wu S, et al. Intravenous Versus Oral Antibiotics for Postdischarge Treatment of Complicated Pneumonia

10

33

14

45

8

43

12

40

0

10

20

30

40

50

60

Articles by or aboutPCORI

Articles that Cite orMention PCORI Work

Num

ber o

f Jou

rnal

Art

icle

s38

46

3539

19

34

18

26

3 4 1 60

10

20

30

40

50

60

Q2 Q3 Q4 Q1

Num

ber o

f Jou

rnal

Art

icle

s

Journal PublicationsQ1-17 UpdateOut of the 39 articles resulting from PCORI-funded projects in Q1-17, 26 were empirical results, and 6 of those were CER results.

Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1

Articles Resulting from PCORI-funded Projects

Other Relevant Articles

All Articles

All Empirical Results

CERResults

Key

*Note: Current quarter counts can be artificially low because some articles are not indexed right away

CERResults

Q1 2017Q4 2016Q3 2016Q2 2016

13

Page 14: Dashboard Review First Quarter of FY-2017€¦ · Shah SS, Srivastava R, Keren R, Wu S, et al. Intravenous Versus Oral Antibiotics for Postdischarge Treatment of Complicated Pneumonia

High Altmetric Scores PCORI Funded Publications from Q1-17

Altmetric Publication Summary

Bryant-Stephens T, et al. Home Visits are Needed to Address Asthma Health Disparities in Adults. J Allergy Clin Immunol. 2016 Oct 21. pii: S0091-6749(16)31218-0. (link)

Perspective: Explores barriers to reducing asthma morbidity and mortality in low-income and minority patients. Researchers conclude that in-home visits are necessary for understanding SES barriers to decrease mortality and morbidity of asthma.

Shah SS, Srivastava R, Keren R, Wu S, et al. Intravenous Versus Oral Antibiotics for Postdischarge Treatment of Complicated Pneumonia. Pediatrics. 2016; December 138(6):e20161692 (link)

CER Results: Compares the effectiveness of oral and intravenous (PICC) antibiotic treatment for complicated pneumonia in children. The study found no increased efficacy of PICC compared to oral antibiotics, but higher levels of complications and adverse reactions with PICC.

Hess EP, et al. Shared decision making in patients with low risk chest pain: prospective randomized pragmatic trial. BMJ. 2016 Dec 5;355:i6165. (link)

CER Results: Compares usual care to decision aid (patient actively engages in decision-making process) and found that, using the decision aid, patients at low risk for coronary syndrome safely decreased the rate of admission to an observation unit for testing.

Martin MA, et al. Care transition interventions for children with asthma in the emergency department. J Allergy Clin Immunol. 2016 Dec;138(6):1518-1525. (link)

Review: Investigates ED care transition interventions for children. Evidence to date suggests that ED care transition interventions should consider expanding beyond the ED to bridge the multiple sectors children with asthma navigate, including health care settings, homes, schools, and community spaces.

These 4 publications from Q1-17 have high Altmetric scores, indicating attention in news articles (red), on social media (blues), and in blogs (gold).

14

Page 15: Dashboard Review First Quarter of FY-2017€¦ · Shah SS, Srivastava R, Keren R, Wu S, et al. Intravenous Versus Oral Antibiotics for Postdischarge Treatment of Complicated Pneumonia

PCORnetDesignated Research Projects

As of Q1-2017, there are 19 PCORnet Designated research projects underway. The target for 2017 is 24 Designated studies underway, including 4 externally-funded or co-funded studies.

1720 20

3

4 4

4

17 171

2 2

0

10

20

30

Q2-16 Q3-16 Q4-16 Q1-17 Q2-17 Q3-17 Q4-17

Proj

ects

PCORnet-Designated Research Projects Underway

(Cumulative)

NA

2017 Target: 24 Studies Underway,

4 Externally Funded or Co-funded

*PCORI-Funded: includes designated PCORnet Demonstration projects and

PCORI projects that use PCORnet

15

Page 16: Dashboard Review First Quarter of FY-2017€¦ · Shah SS, Srivastava R, Keren R, Wu S, et al. Intravenous Versus Oral Antibiotics for Postdischarge Treatment of Complicated Pneumonia

PCORnetDesignated Research Projects

First Externally-Funded PCORnet-Designated Study – the INVESTED Trial A comparative effectiveness study of doses of influenza vaccine among patients with a history of myocardial infarction or heart failure. Funded by the NIH, this study seeks to enroll and randomize 9,300 patients, and will leverage 7 Clinical Data Research Networks (CDRNs). (NCT02787044)

16

Page 17: Dashboard Review First Quarter of FY-2017€¦ · Shah SS, Srivastava R, Keren R, Wu S, et al. Intravenous Versus Oral Antibiotics for Postdischarge Treatment of Complicated Pneumonia

39

6267

110 110117

95 95

2722

1421 17

24 24 23

25 187

18 12 16 160

20

40

60

80

100

120

Num

ber

Engagement Awards

7

2924

38

24

3947

19

5 12 9 17 14 16 1880

20

40

60

Cycle 1(2014)

Cycle 2(2015)

Cycle 3(2015)

Cycle 4(2015)

Cycle 5(2015)

Cycle 6(2016)

Cycle 7(2016)

Cycle 8(2016)

Num

ber

Meeting/Conference Support

Engagement AwardsQ1-17 Update

LOIs Received

Applications

Awards

Applications

Awards

Not Yet Awarded

17